Study identification

EU PAS number

EUPAS19188

Study ID

19189

Official title and acronym

Use of antidepressant drugs and its association with risk of stroke, frequency of hospitalization, and mortality in an elderly population: a descriptive and analytic cohort study

DARWIN EU® study

No

Study countries

Spain

Study description

This is an observational study which will describe the use of antidepressants in an elderly population and assess its association with stroke, hospitalizations due to stroke and death in an elderly population during 2009-2015.A retrospective descriptive drug utilization study in a population aged over 65 and registered in the System for the Development of Research in Primary Care database (SIDIAP). Demographic and clinical patient characteristics, selected co-morbidities, clinical indications of antidepressant use, prescribed active ingredient of antidepressant, selected co-medications, prescribed dose and duration of antidepressants, switchers and discontinuers will be described. Prevalence of antidepressant use and rate of switchers and discontinuers will be measured.A retrospective study with matched cohorts will be conducted in a population aged over 65 and registered in the System for the Development of Research in Primary Care database (SIDIAP). Cases are incident users of antidepressant medication (tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants), controls will not have used this type of medication. The research will evaluate the association of new prescription of antidepressants for any indication and occurrence of first episode of stroke, hospitalization or death. The information will be obtained from SIDIAP database (which has information of 5.8 million primary care patients from Intitut Català de la Salut), DATAMART® database (Pharmaceutical dispensation information from Catalan Health Service) and CMBD database (Hospital discharge registry from General Hospital of National Health System).

Study status

Ongoing
Research institutions and networks

Institutions

Contact details

Luisa Ibañez

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
EU institutional research programme
Other

More details on funding

Instituto de Salud Carlos III, European Regional Development Fund (FEDER))
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable